Biomodal
3 known investors
biomodal develops a multi-modal genomic sequencing platform, including its 6-base sequencing and duet evoC products, that profiles epigenetic (5mC, 5hmC), genetic, and fragmentomics biomarkers from a single DNA sample. Its technology is applied to liquid biopsy workflows for applications such as cancer detection.
Investors Β· 3
Frequently asked questions
- What does Biomodal do?
- biomodal develops a multi-modal genomic sequencing platform, including its 6-base sequencing and duet evoC products, that profiles epigenetic (5mC, 5hmC), genetic, and fragmentomics biomarkers from a single DNA sample. Its technology is applied to liquid biopsy workflows for applications such as cancer detection.
- Who are Biomodal's investors?
- Biomodal's investors include JIMCO, New Science Ventures, Ahren Innovation Capital.